Table 2.
Comparison of Stable Transgene Expression Achieved with HSB Transposase Expressed by NMDU3, CMV, or EF1-α Promoter in K-562, Jurkat, and Primary Human CD34+ Cells
Cell type | CMV-HSB-mediated gene expression (% eGFP ± SEM) | MNDU3-HSB-mediated gene expression (% eGFP ± SEM) | EF1-α-HSB-mediated gene expression (% eGFP ± SEM) | Fold increase |
---|---|---|---|---|
K-562 (n = 2) | 76.0 ± 1.1 | 68.1 ± 13.6 | 85.6 ± 0.7 | 1.1 (p = 0.18) |
Jurkat (n = 2) | 8.0 ± 2.1 | 7.6 ± 1.6 | 16.6 ± 2.3 | 2.1 (p = 0.006) |
LTC-CD34+ (n = 3) | 3.8 ± 0.8 | 2.1 ± 1.2 | 6.9 ± 1.8 | 1.8 (p = 0.05) |
Abbreviations: CMV, cytomegalovirus; EF1-α, elongation factor 1α; MNDU3, modified myeloproliferative sarcoma virus long terminal repeat enhancer–promoter.